A recent study by International Flavors & Fragrances (IFF) reveals that while Indian GLP-1 users are cutting portion sizes, household spending on traditional snacks remains resilient. This creates a complex environment for FMCG companies, which must now balance traditional offerings with a growing demand for nutrient-dense, functional foods. Investors should track how food manufacturers adapt their product pipelines to meet these changing consumer needs.
A new study released on August 25, 2026, by International Flavors & Fragrances (IFF) highlights a notable shift in the dietary habits of GLP-1 medication users in India. The research, titled 'Inside the India GLP-1 Consumer Journey,' which surveyed users in Delhi, Mumbai, and Bengaluru, shows that individuals are actively reducing their meal portions. Specifically, many users are cutting back on staples like rice and chapatis as a direct result of their medication.
However, this reduction in individual appetite is not immediately reflecting in overall household grocery baskets. The study indicates that traditional snack items, including biscuits, sweets, and full-fat dairy products, continue to be purchased at similar rates. This persistence is largely attributed to family dynamics, where other household members do not share the restricted diet of the user. Consequently, for food brands, demand for high-calorie, traditional snacks remains anchored in the domestic market despite the changing needs of individual GLP-1 users.
The Shift Toward Functional Nutrition
The report identifies significant changes in consumer perception. Approximately 90% of respondents noted a change in how food tastes or feels, with a growing preference for softer textures and easy-to-digest meal options. Furthermore, 74% of participants are now more diligent about reading food labels, suggesting that users are becoming increasingly conscious of what they consume. This signals an opportunity for FMCG companies to innovate.
For investors, the strategic implication lies in product formulation. The market for nutrient-dense portions—those emphasizing high protein and fiber content—is expanding. Companies that can bridge the gap between 'snackable' products and the need for functional nutrition may find a competitive advantage. There is a clear market vacuum for products that allow users on medication to engage in social eating without the discomfort associated with larger, traditional portions.
Investor Monitorables and Risks
While the findings point toward a long-term change in consumer habits, the transition will likely be gradual. One key risk for food manufacturers is the potential for slower-than-expected adoption of reformulated or 'better-for-you' products in the Indian market, where price sensitivity and taste remain dominant factors. Investors should watch for how major FMCG players adapt their R&D and product launches to address the demand for functional nutrition.
Additionally, the 'start-stop' nature of some medication usage could lead to unpredictable demand patterns, making it difficult for companies to forecast inventory needs accurately. The final success of brands catering to this segment will depend on their ability to balance sensory appeal with the functional benefits that this specific group of consumers is now actively seeking.